Karachi, Citi Pharma Limited informed Pakistan Stock Exchange about the recommendations made by the board of directors in the meeting held at Lahore on February 21, 2022.
The agenda of the meeting was discussion of profit and loss account for quarter ended December 31, 2021 which portrayed a loss of Rs. 261,697,724 with loss per share 111 basic and diluted respectively.
Further, nil payment of cash dividend, bonus shares and right shares was agreed.
Citi Pharma Limited incorporated as a private limited company in Pakistan on October 08, 2012. The principal activity of the company is manufacturing and sale of pharmaceuticals, medical chemicals and botanical products. The factory is located at 3km Head Balloki road, Kasur. It has a land of 47 acres and has more than 800,000 Sq. Feet covered area.
The total numbers of shares are 207,692,000. The Earnings per share is 32.36 in 2020 which was 6.18 in 2019. The Profit after Taxation is 145,635,000 in 2020 which was 27,804,000 in 2019.